Caoimhe Vallely-Gilroy

Caoimhe Vallely-Gilroy has a diverse range of work experience in the healthcare and pharmaceutical industry. Caoimhe is currently the Director Healthcare Innovation - DayOne (ad-Interim) at Basel Area Business & Innovation, starting in April 2023. Caoimhe is also an Independent Advisor - Pharma and Lifesciences at Health Innovation Research Alliance Northern Ireland (HIRANI) since January 2023.

Previously, Caoimhe Vallely-Gilroy worked as a Consultant Chief Clinical Research Officer and Head of Biomarker Discovery at Allelica, Inc from February 2023 to May 2023. Prior to that, they held various positions at the Healthcare Business of Merck, including Global Head of Digital Health & Therapeutics from January 2021 to January 2023, and Head of Data Analytics and Strategy, Healthcare from November 2019 to January 2021.

Caoimhe also had roles at Merck KGaA, Darmstadt, Germany as the Director, Head of Clinical Trial Biosample Management from May 2017 to August 2019, and at Roche as the Biomarker Operations Therapeutic Area Leader, I2ON from March 2016 to May 2017, and as Senior Project Manager (Biosamples) - Neuroscience from April 2013 to March 2016.

Additionally, they worked at Novartis Pharma AG as a Biomarker Clinical Coordinator from December 2010 to March 2013, at Actelion Pharmaceuticals Ltd as a Regulatory Submissions Coordinator from August 2009 to December 2010, at Fisher Bioservices as a Project Manager from 2008 to 2009, and at the Friedrich Miescher Institute for Biomedical Research as a Post-Graduate research Student from August 2007 to August 2008.

Caoimhe Vallely-Gilroy has a diverse education history. Caoimhe started their higher education journey at Queen's University Belfast, where they earned a Bachelor of Science (BSc Hons) degree in Genetics from 2004 to 2007. Following this, they pursued a Master of Science (MSc) degree in Biomedical Science at Ulster University from 2008 to 2010.

Continuing their academic pursuits, Caoimhe then attended The University of Edinburgh from 2011 to 2015, where they obtained a Master of Science (MSc) degree in Translational Medicine. This program likely provided their with a deeper understanding of the process of translating medical research into practical applications.

Seeking further specialization in their field, Caoimhe completed the Certified Clinical Research Coordinator (CCRC) program offered by the Association of Clinical Research Professionals from 2012 to 2019. This certification enhanced their expertise in clinical research coordination.

Currently, Caoimhe is pursuing a Doctor of Philosophy (PhD) degree at UCL. Their PhD focuses on Clinical Trials and Methodology, indicating a research interest in the design and conduct of clinical trials. The anticipated completion date for their PhD is in 2025.

Additionally, Caoimhe holds the CCRC certification from the ACRP, although the specific obtained month and year are not provided.

Overall, Caoimhe Vallely-Gilroy has a comprehensive educational background in genetics, biomedical science, translational medicine, and clinical research coordination, and is currently engaged in doctoral research in clinical trials and methodology.